AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2021
May 11, 2021
29755_dirs_2021-05-11_ccb3dca9-cd4b-431f-a063-18eea1b44356.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2021-05-07
Reporting Person: Strom Carrie C (SVP & Pres Global Allerg Aesth)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-07 | Common Stock, $0.01 par value | F | 234 | $116.08 | Disposed | 58991 | Direct |
More from AbbVie Inc.
Earnings Release
2026
Jul 6
Annual Report
2026
Jun 24
Call Transcript
2026
Jun 22
M&A Activity
2026
Jun 22
Call Transcript
2026
Jun 9
Regulatory Filings
2026
Jun 1
Call Transcript
2026
May 13
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Call Transcript
2026
May 8